United States v. Faith Blake

695 F. App'x 859
CourtCourt of Appeals for the Sixth Circuit
DecidedJune 7, 2017
Docket15-6114
StatusUnpublished

This text of 695 F. App'x 859 (United States v. Faith Blake) is published on Counsel Stack Legal Research, covering Court of Appeals for the Sixth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Faith Blake, 695 F. App'x 859 (6th Cir. 2017).

Opinion

COLE, Chief Judge.

Faith Blake appeals her sentence for conspiracy to distribute controlled substances and failure to appear at her bond hearing, arguing that her 528-month sentence was procedurally and substantively unreasonable. The district court correctly applied the challenged enhancements and imposed a substantively reasonable sentence. We, therefore, affirm Blake’s sentence.

I. BACKGROUND

Faith Blake owned Elite Care Pain Clinic (“Elite Care”), and she and her mother, Barbara Lang, owned and operated Superior One Medical Clinic (“Superior One”), both in Chattanooga, Tennessee. These clinics operated as “pill mills” that prescribed addictive pain medication to clients who did not medically need it. A grand jury charged Blake, Lang, nurse practitioner Charles Larmore, and pediatrician Jerome Sherard with conspiring to distribute controlled substances, in violation of 21 U.S.C. §§ 846, 841(a)(1) and (b)(1)(C), and with maintaining premises for the purpose of distributing controlled substances, in violation of 21 U.S.C. § 856(a)(1). A superseding indictment charged Blake with failure to appear for court proceedings, in violation of 18 U.S.C. § 3146.

On December 19, 2013, Blake pleaded guilty to two counts of conspiring to distribute and disperse Schedule II, III, and IV controlled substances, in violation of 21 U.S.C. §§ 846, 841(a)(1), (b)(1)(C), and (b)(1)(E), failing to appear at her bond revocation hearing, in violation of 18 U.S.C. §§ 3146(a)(1) and (b)(1)(A)(I), and obstructing and impeding the administration of internal revenue laws, in violation of 26 U.S.C. § 7212(a). As part of her plea agreement, Blake stipulated that “the majority of the prescriptions [issued at Supe *861 rior One and Elite Care] were not issued for a medical purpose.” (Plea Agreement, R. 158, PagelD 546.) She also stipulated that, after being indicted and released pending. trial, she fled the jurisdiction, failed to appear in court as scheduled, and was later apprehended in Maryland under an assumed name.

On August 1, 2014, Blake moved to withdraw her guilty plea. After an evidentiary hearing, the district court denied the motion.

The Presentence Investigation Report (“PSR”) determined that Blake was responsible for 28 kilograms of oxycodone, which yielded a base offense level of 38. The PSR recommended two-level enhancements for (1) possession of a dangerous weapon under U.S.S.G. § 2D1.1(b)(1), (2) maintaining the premises for the purpose of distributing controlled substances under U.S.S.G. § 2D1.1(b)(12), (3) committing the offense as part of a pattern of criminal conduct engaged in as a livelihood under U.S.S.G. § 2D1.1(b)(15)(E), and (4) obstruction of justice under U.S.S.G. § 3C1.1. The PSR also recommended a four-level leadership enhancement. After the enhancements, Blake’s combined adjusted offense level was 50. Because the maximum Guidelines offense level is 43, the PSR set Blake’s total offense level at 43. Blake’s effective sentencing Guidelines range under U.S.S.G. § 5G1.2(d) was 600 months of imprisonment.

Blake objected to each of the enhancements and requested a downward departure and variance from the Guidelines range. At sentencing, the district court overruled all of Blake’s objections but granted a downward variance because Blake’s offense level was largely driven by the high drug quantity. The district court imposed a sentence of 528 months of imprisonment. Blake timely appealed.

II. ANALYSIS

We review a criminal sentence for procedural and substantive unreasonableness under “a deferential abuse of discretion standard.” Gall v. United States, 552 U.S. 38, 41, 128 S.Ct. 586, 169 L.Ed.2d 445 (2007). “An abuse of discretion occurs when the reviewing court is left with the definite and firm conviction that the sentencing court committed a clear error of judgment.” United States v. Coppenger, 775 F.3d 799, 802-03 (6th Cir. 2015). A sentence may be procedurally unreasonable if the district court failed to calculate or improperly calculated the Guidelines range, treated the Guidelines as mandatory, failed to consider the 18 U.S.C. § 3553(a) factors, selected a sentence based on clearly erroneous facts, or failed to explain adequately the chosen sentence. United States v. Adkins, 729 F.3d 559, 563 (6th Cir. 2013). A sentence may be substantively unreasonable if the district court chose the sentence arbitrarily/ based the sentence on impermissible factors, or unreasonably weighed a pertinent factor. Id,

A. Enhancement for Maintenance of Facility for the Purpose of Distributing Controlled Substances

Under U.S.S.G. § 2D1.1(b)(12), a defendant who “maintain[s] a premises for the purpose of manufacturing or distributing a controlled substance” is subject to a two-level enhancement. Blake argues that the enhancement cannot apply to her because no drugs were manufactured or distributed at Superior One or Elite Care. This circuit “has not settled on the proper standard of review for assessing such enhancements.” United States v. Bell, 766 F.3d 634, 636 (6th Cir. 2014) (comparing United States v. Jackson-Randolph, 282 F.3d 369, 390 (6th Cir. 2002) (reviewing for clear error) with United States v. Sweet, 630 F.3d 477, 480 (6th Cir. 2011) (review *862 ing de novo)). Here, we need not decide the standard of review because the issuance of a prescription qualifies as distribution under either standard.

“Because the [U.S. Sentencing] Commission adopted language nearly identical to the pre-existing drug house statute to describe the enhancement, it is fair to assume that it meant to incorporate prior interpretations of the statute.” United States v. Johnson, 737 F.3d 444, 447 (6th Cir. 2013) (internal citations omitted) (comparing U.S.S.G. § 2D1.1(b)(12) with 21 U.S.C. § 856(a)(1)).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Woods
604 F.3d 286 (Sixth Circuit, 2010)
Gall v. United States
552 U.S. 38 (Supreme Court, 2007)
United States v. Sweet
630 F.3d 477 (Sixth Circuit, 2011)
United States v. Lewis J. Smith
73 F.3d 1414 (Sixth Circuit, 1996)
United States v. Marie Antoinette Jackson-Randolph
282 F.3d 369 (Sixth Circuit, 2002)
United States v. Willie Green, Jr.
305 F.3d 422 (Sixth Circuit, 2002)
United States v. Mike Darwich
337 F.3d 645 (Sixth Circuit, 2003)
United States v. Regis Adkins
729 F.3d 559 (Sixth Circuit, 2013)
United States v. Peroceski
520 F.3d 886 (Eighth Circuit, 2008)
United States v. Conatser
514 F.3d 508 (Sixth Circuit, 2008)
United States v. Curry
536 F.3d 571 (Sixth Circuit, 2008)
United States v. Carlos Johnson
737 F.3d 444 (Sixth Circuit, 2013)
United States v. Nancy Sadler
750 F.3d 585 (Sixth Circuit, 2014)
United States v. Tamral Guzman
571 F. App'x 356 (Sixth Circuit, 2014)
United States v. Curtis Bell, Jr.
766 F.3d 634 (Sixth Circuit, 2014)
United States v. Jack Coppenger, Jr.
775 F.3d 799 (Sixth Circuit, 2015)
Johnson v. United States
576 U.S. 591 (Supreme Court, 2015)
United States v. Denise Huffman
529 F. App'x 426 (Sixth Circuit, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
695 F. App'x 859, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-faith-blake-ca6-2017.